372 filings
Page 5 of 19
8-K
ay4q 284j2
25 Feb 21
Assembly Biosciences Reports Fourth Quarter and Year End 2020 Financial Results and Recent Highlights
4:12pm
8-K
cfqm 70emb
17 Feb 21
Departure of Directors or Certain Officers
4:55pm
UPLOAD
cm2zm32mw2h yrwyirj
11 Feb 21
Letter from SEC
12:00am
8-K
9vjxyg
27 Jan 21
Amendments to Articles of Incorporation or Bylaws
4:00pm
CORRESP
22svm ecwxz
12 Jan 21
Correspondence with SEC
12:00am
UPLOAD
65tcucxog0c0i4xk0wcl
29 Dec 20
Letter from SEC
12:00am
8-K
a1j47klees87pfu5kpq6
8 Dec 20
Cost Associated with Exit or Disposal Activities
4:07pm
8-K
s3vyuga8gb0pnr2
17 Nov 20
Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators
4:07pm
8-K
knc8mqb0g gm84f5
5 Nov 20
Assembly Biosciences Reports Third Quarter 2020 Financial Results and
4:40pm
8-K
oxhu6n qf
21 Oct 20
Assembly Biosciences Appoints Gina Consylman to Board of Directors
5:12pm
EFFECT
aug4dcr n26bnz0l
8 Sep 20
Notice of effectiveness
12:15am
CORRESP
obi51jey
3 Sep 20
Correspondence with SEC
12:00am
UPLOAD
7e7me0lq43gyvv2
2 Sep 20
Letter from SEC
12:00am
S-8
lmabvpoyipu b0f
28 Aug 20
Registration of securities for employees
4:21pm
8-K
4485 fv5j
27 Aug 20
Other Events
4:34pm
8-K
ut8zojm0a2d ca0y
5 Aug 20
Assembly Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
4:22pm
8-K
16bnr2iplomdk jl
20 Jul 20
Entry into a Material Definitive Agreement
6:45am